Erythromycin/Zinc acetate dihydrate

红霉素/醋酸锌二水合物

Report date: 2026/03/04 20:01:44

Base Information

Drug NameErythromycin/Zinc acetate dihydrate
Drug Alias Name红霉素醋酸锌凝胶
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsAcne Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes ErythromycinZinc acetate dihydrate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAcne Vulgaris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A